Literature DB >> 2310435

Moyamoya disease presenting with chorea.

K Watanabe1, T Negoro, M Maehara, I Takahashi, K Nomura, K Miura.   

Abstract

Three children with moyamoya disease are reported whose initial and predominant manifestations were choreic movements. Two of the patients presented with unsteady gait and the other with clumsiness. Choreic movements were recurrent and were often triggered by excitement, emotional tension, or crying. They occurred unilaterally or bilaterally and often alternated between the right and left. Moyamoya disease must be considered in the differential diagnosis of acquired chorea in children.

Entities:  

Mesh:

Year:  1990        PMID: 2310435     DOI: 10.1016/0887-8994(90)90077-e

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

1.  Late-onset chorea after cerebral revascularization as a clinical manifestation of moyamoya disease.

Authors:  Pilar Enríquez-Ruano; Cristian Eduardo Navarro; Natalia Penagos; Oscar Mauricio Espitia
Journal:  Neurol Sci       Date:  2021-03-22       Impact factor: 3.307

2.  A case of moyamoya disease presenting with chorea.

Authors:  Wei Zheng; Masahiko Wanibuchi; Toshiaki Onda; He Liu; Izumi Koyanagi; Kenji Fujimori; Kiyohiro Houkin
Journal:  Childs Nerv Syst       Date:  2005-04-30       Impact factor: 1.475

3.  Hemichorea-hemiballismus caused by postoperative hyperperfusion after clipping of a giant unruptured middle cerebral artery aneurysm.

Authors:  Soichi Oya; Naoaki Fujisawa; Toru Matsui
Journal:  Surg Neurol Int       Date:  2015-05-21

4.  Dystonia, myoclonus, and encephalopathy in a single patient: A rare association of moyamoya.

Authors:  Ujjawal Roy; Urmila Das; Ajay Panwar; Prabhat Kumar Lal
Journal:  Ann Afr Med       Date:  2016 Oct-Dec

5.  Vascular Parkinsonism with Dystonia in Moyamoya Disease: An Expansion of Movement Disorder Phenomenology.

Authors:  Rohan R Mahale; Rohin Dubbal; Hansashree Padmanabha; Pooja Mailankody
Journal:  Ann Indian Acad Neurol       Date:  2022-04-06       Impact factor: 1.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.